Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8983353 | 0.83 | GPR35 (0.50) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL30255416 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL530340 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL11802004 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL7434038 | 0.79 | TDP1 (0.52) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL39472 | 0.79 | HPGD (0.78) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL28056476 | 0.77 | L3MBTL1 (0.81) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL26509809 | 0.77 | ALDH1A1 (0.67) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL8891 | 0.76 | RAB9A (0.68) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL7296254 | 0.76 | GPR35 (0.50) | ALDH1A1TDP1HPGDKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022112944-A1 | NANOSYSTEM FOR DIAGNOSIS AND PHOTOTHERMAL TREATMENT OF TUMORS | UNIVERSITÀ DEGLI STUDI DI PALERMO (IT) | 2022-06-02 | — | — | WO | claimed |
| WO-2022005988-A2 | SOLID SUPPORT FOR SYNTHESIZING NUCLEIC ACID SEQUENCES AND METHODS FOR MAKING AND USING | UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-01-06 | — | — | WO | claimed |
| EP-3291792-A2 | PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME | L'Oréal (FR) | 2018-03-14 | — | — | EP | claimed |
| CN-107709306-A | NRF2 modulators | 葛兰素史密斯克莱知识产权发展有限公司 | 2018-02-16 | — | — | CN | claimed |
| WO-2016177908-A2 | PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME | L'OREAL (FR) | 2016-11-10 | — | — | WO | claimed |
| EP-2206706-B1 | Method for producing acylamide compounds | SALTIGO GMBH (DE) | 2013-07-10 | — | — | EP | claimed |
| EP-2594651-A1 | Analysis of methylation sites | Vilnius University (LT) | 2013-05-22 | — | — | EP | claimed |
| EP-2206705-B1 | Method for manufacturing benzomorpholine derivatives through hydration of o-nitrophenoxycarbonyl compounds | SALTIGO GMBH (DE) | 2013-03-13 | — | — | EP | claimed |
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-28 | — | — | US | claimed |
| CN-102939292-A | Spirocyclic compounds and their use as therapeutic agents and diagnostic probes | UNIV BASEL | 2013-02-20 | — | — | CN | claimed |
| EP-1798250-B1 | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | IMEC INTER UNI MICRO ELECTR (BE) | 2008-09-03 | — | — | EP | claimed |
| EP-1940452-A2 | CGRP PEPTIDE ANTAGONISTS AND CONJUGATES | Amgen, Inc (US) | 2008-07-09 | — | — | EP | claimed |
| US-20070272003-A1 | 2-(2-{2-[2-(2-{2-[2-(11-mercaptoyldisulfanyl-undecyloxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy} acetic acid pentafluorophenyl ester; poly(ethylene oxide) groups resist nonspecific adsorption and enhance the specific affinity interactions | IMEC (BE) | 2007-11-29 | — | — | US | claimed |
| EP-1798250-A2 | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM vzw (IMEC) (BE) | 2007-06-20 | — | — | EP | claimed |
| WO-2007048026-A2 | CGRP PEPTIDE ANTAGONISTS AND CONJUGATES | AMGEN INC. (US) | 2007-04-26 | — | — | WO | claimed |
| EP-0620216-B1 | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-01-08 | — | — | EP | claimed |
| EP-0622361-B1 | Heterocyclic compounds as bradykinin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-10-04 | — | — | EP | claimed |
| EP-0392384-B1 | Targeted forms of methyltrithio antitumor agents | AMERICAN CYANAMID CO (US) | 1998-02-18 | — | — | EP | claimed |
| EP-0392384-A2 | Targeted forms of methyltrithio antitumor agents | AMERICAN CYANAMID COMPANY (US) | 1990-10-17 | — | — | EP | claimed |
| US-4180571-A | Arylmalonamido-1-oxadethiacephalosporins | SHIONOGI & CO., LTD. (JP) | 1979-12-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | POLL, POLRMT, POLN | ALDH1A1 1877/4885TDP1 296/4885NPC1 3926/4885 |
| US-20070272003-A1 | 2-(2-{2-[2-(2-{2-[2-(11-mercaptoyldisulfanyl-undecyloxy)ethoxy]ethoxy}ethoxy)ethoxy]ethoxy} acetic acid pentafluorophenyl ester; poly(ethylene oxide) groups resist nonspecific adsorption and enhance the specific affinity interactions | EBPL, AEBP2, NAPA | ALDH1A1 1605/4885TDP1 3027/4885NPC1 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.